Ropivacaine 0.75% (Naropin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ropivacaine 0.75% (Naropin), covering 2025-11-17 to 2025-11-17. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Analgesic Effect of the Perineal Infiltration of Ropivacaine 0.75% Versus Placebo in Post-episiotomy Perineal Pain [Phase 3]